S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University

S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University

SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- The inaugural S2S China Symposium has announced the finalists of its 2026 program. Co-hosted by RA Capital Management and Qiming Venture Partners, S2S China is the China chapter of Science2Startup, an...

Ractigen Therapeutics to Present First-in-Human RNA Activation Data in Duchenne Muscular Dystrophy as a Late-Breaking Oral Presentation at the 31st Annual Congress of the World Muscle Society

Ractigen Therapeutics to Present First-in-Human RNA Activation Data in Duchenne Muscular Dystrophy as a Late-Breaking Oral Presentation at the 31st Annual Congress of the World Muscle Society

Late-Breaking selection at the 31st Annual World Muscle Society Congress — a designation reserved for findings the program committee determines to be of immediate importance to the field Presentation expected to provide the first clinical evidence...

Tomonari Abe, President of Abe Yoando Pharma, Selected as First Japanese Speaker at Longevity Investors Conference 2026 in Switzerland

Tomonari Abe, President of Abe Yoando Pharma, Selected as First Japanese Speaker at Longevity Investors Conference 2026 in Switzerland

- Head of 295-year-old Japanese Pharmaceutical Pioneer to Present Asia's Longevity Growth Strategies and Bioscientific Research Initiatives at Prestigious Conference - TOKYO and GSTAAD, Switzerland, Sept. 14, 2026 /PRNewswire/ -- Abe Yoando Pharma...

Singapore to Host Shared Services Leaders at 29th Asian Shared Services & Outsourcing Week 2026 This October

Singapore to Host Shared Services Leaders at 29th Asian Shared Services & Outsourcing Week 2026 This October

Join Asia's shared services and GBS community for AI insights, sponsor-led sessions and networking, 20–23 October 2026. SINGAPORE, Sept. 14, 2026 /PRNewswire/ -- With five weeks to go, the 29th Asian Shared Services & Outsourcing Week (SSOW)...

ECARX to Present at the Sidoti Small-Cap Investor Conference on September 24, 2026

ECARX to Present at the Sidoti Small-Cap Investor Conference on September 24, 2026

LONDON, Sept. 10, 2026 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a leading global automotive intelligence business, today announced that its Chief Operating Officer, Peter Cirino is scheduled to present at the...

Huayan Robotics to Present Chinese Intelligent Manufacturing Solution at IMTS 2026

Huayan Robotics to Present Chinese Intelligent Manufacturing Solution at IMTS 2026

CHICAGO, Sept. 7, 2026 /PRNewswire/ -- From September 14 to 19, Huayan Robotics will participate in IMTS 2026 at McCormick Place in Chicago, the United States (Booth No.: 236746). Started in 1927 and held biennially, this 99-year-old manufacturing...

"Savour the Tastes of Home in Hundred Ways" Returns with Phase 2 Rewards: "McDull Dining Treats" & Link Fresh Market's "Age Defying Wellness Project" Bring Delicious Treats and Enjoyment

"Savour the Tastes of Home in Hundred Ways" Returns with Phase 2 Rewards: "McDull Dining Treats" & Link Fresh Market's "Age Defying Wellness Project" Bring Delicious Treats and Enjoyment

" McDull Dining Treats Phase 2" Redemption: Collect stamps upon spending to redeem brand-new Mrs. Mak & McDull themed ceramic tableware sets Spend at 24 designated Link Shopping Centres & Fresh Markets using Octopus or JoyYou Card to earn...

First Mold Returns to Meximold 2026: Enhanced Large‑Part Capacity for North America

First Mold Returns to Meximold 2026: Enhanced Large‑Part Capacity for North America

SILAO DE LA VICTORIA, Mexico, Aug. 21, 2026 /PRNewswire/ -- First Mold, a global parts manufacturer, will exhibit at Meximold 2026 on October 14-15 at the Queretaro Convention Center in Santiago de Queretaro, Qro., Mexico. This is the second...

Dizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026

Dizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026

SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- Dizal (SSE: 688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that the latest clinical data on its novel...

Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona

Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona

NEW YORK and SUZHOU, China, Aug. 13, 2026 /PRNewswire/ -- Accro Bioscience, a clinical-stage biotechnology company pioneering the development of novel therapeutics for immune mediated diseases, today announced that it will present efficacy and...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • menu
    menu